Alendronate better than risedronate at increasing BMD

Article

Weekly treatment with alendronate is more effective in building bone in the hip and spine than weekly risedronate, according to a new head-to-head study of the drugs.

Weekly treatment with alendronate is more effective in building bone in the hip and spine than weekly risedronate, according to a new head-to-head study of the drugs. The findings were from a post-hoc analysis of FACT (Fosamax Actonel Comparator Trials), a double-blind, randomized trial of alendronate and risedronate. More than 1,000 postmenopausal women with and without osteoporosis were enrolled in the 12-month trial.

Weekly alendronate (70 mg) was significantly more effective in increasing hip trochanter, lumbar spine, and total hip bone mineral density (BMD), regardless of a patient's osteoporotic status. In women with osteoporosis, alendronate increased BMD by 3.6%, 3.6%, and 2.1% in those sites, respectively, compared with 2.0, 2.5, and 1.0 for risedronate (35 mg). The osteoporotic patients on alendronate also had greater decreases in biochemical markers indicative of their condition than did their counterparts taking risedronate. No significant differences were seen between the two treatments in adverse events, including upper gastrointestinal problems.

Bonnick S, Hochberg M, Broy S, et al. Comparison of once-weekly alendronate and once-weekly risedronate in the osteoporotic subgroup from the FACT study. Poster presented during the 6th International Symposium on Osteoporosis: Current Status and Future Directions in Washington, D.C.

Recent Videos
Baher Mankabady, MD, highlights safety of buprenorphine against OUD in pregnancy | Image Credit: linkedin.com.
Devon Ramaeker, MD
Elizabeth Gandee, APRN-CNP, highlights gaps in women's menopause knowledge | Image Credit: wexnermedical.osu.edu
Doula highlights how postpartum care is failing new mothers | Image Credit: linkedin.com
Nicky Herrick MD; and Anushree Agarwal, MD, MBBS, highlight their study on cardiac arrhythmias in pregnancy | Image Credit: © Igor Borodin - stock.adobe.com.
Lisa Becht, MD, FACOG, sheds light on fertility awareness | Image Credit: havingbabies.com.
First US national HPV conference highlights advances in cancer prevention | Image Credit: uchealth.com.
Mitchell Creinin, MD, reports estetrol pill eases menstrual symptoms | Image Credit: health.ucdavis.edu
1 expert is featured in this series.
Susanna Mitro, PhD, reveals ethnic disparities in uterine fibroid diagnosis | Image Credit: divisionofresearch.kaiserpermanente.org.
Related Content
© 2025 MJH Life Sciences

All rights reserved.